Counterfeit Drugs and Supply Chain Security
|
|
- Rosalyn Long
- 6 years ago
- Views:
Transcription
1 Counterfeit Drugs and Supply Chain Security Rick Mitzner Senior Director, Engineering Technology Pfizer, Inc. Interphex April 21, 2015
2 Tragic Consequences Not If But When and Where May 7, children die in Haiti due to contaminated glycerin in acetaminophen syrup 2 2
3 Threats Across the Supply Chain From raw materials to finished product, threats exist throughout the supply chain Sourcing Production Logistics Market Intentional Adulteration Cargo Theft Diversion Counterfeiting 3
4 Impact on Manufacturing Strategies Where we buy raw materials, manufacture our products, and sell our products is changing Industry Trends Rise of emerging markets Healthcare spending Regional pricing pressures Generics share Increased supply chain complexity and risk Business Models Increased contract manufacturing Increased licensing arrangements Ongoing consolidation What are we doing about it? 4
5 Illicit Activity Impacts All Stages of the Supply Chain From: Raw materials Excipients APIs Components Drug products Packaging & Labeling Storage Distribution 5 5
6 Illicit Activity is Present and Threatens $1000 the Safety of Medicines Counterfeit DVDs $10,000 Illegal drugs $100,000 Counterfeit medicine $1,000,000 The criminal element is present, active, and business savvy Weak criminal penalties Relatively safe for criminals
7 Must Focus on End to End Supply Chain 1 Materials 2 Manufacturing Product 3 Authentication 4 Warehouse Security 5 Cargo Security Market 6 Surveillance Customer Supplier Oversight GMP Material Qualification Risk Mgmt Inspection and testing Security Transportation and logistics GMPs Security Incident reporting Anticounterfeiting Serialization Waste management Implementation of local serialization solutions Compliance with local security features requirements Auditing LSP Mgmt Segregation CTPAT Security Inventory Control GMP and GDP Carrier Assessment Shipment Tracking LSP Assessment Security Reporting of counterfeit signals Education and adoption of controls by distributors 7
8 Supply Chain Security: A Holistic Approach Functional Responsibilities Commercial Operations - Trading partner relationships - Serialization External Supply - Contractor selection - Contractor management Government Affairs - Legislative Influence - Pfizer business positions Procurement Supply Chain Security Team Logistics & Supply - Supplier selection - Supplier management -Logistic center security - Product conveyance security - Cargo Theft/Diversion Quality - Quality Systems - Supplier Quality Mngt - Adulteration - Regulatory Influence Environmental Health & Safety - Returned goods - Waste disposal Packaging Technology - Packaging technology - Serialization Pharm Sci - Supply Chain improvement synergies (front-end/external supply) Communications & Trade Media - Colleague Awareness - Industry Transparency Operational Excellence/ Network Performance - SCS Leadership - Program Owner - Continuous Improvement Global Security -Site security -Anti-Counterfeiting -Incident investigation /response
9 Intentional Adulteration Supplier Selection / Management Material Qualification Quality Agreements Audits Supply Chain Transparency Surveillance Testing Risk Assessment Person in Plant Security Assessments Management Notification / Response Program
10 Cargo Theft/Diversion Physical Site Security Conveyance Security Law Enforcement / Customs Collaboration Threat awareness Third Party Carrier Program Management Notification / Response Program Serialization
11 Global Cargo Theft Risk 11
12 Anti-counterfeiting Serialization Packaging Technology Consumer Education Counterfeit Medicines Laboratories Market Surveillance Program Law Enforcement / Customs / Government Collaborations Influencing Enforcement Legislation Disrupting Counterfeit Manufacturers Management Notification / Response Program Trade Policies/Business Practices
13 Serialization Business Drivers Patient Safety: Insure the integrity of pharmaceutical products throughout the supply chain Counterfeiting deterrent Deter re-introduction of stolen goods into supply chain (with T&T) Allows Authentication through the supply chain epedigree confirmed movement through legitimate supply chain Compliance: Increasing regulations (US and Global) US legislation: requires epedigree with pathway to Track and Trace. Unit level serialization by Nov EU Falsified Medicines Directive: requires serialization and tamper evidency in ~2017/2018 through EU country delegated acts (with pharmacy authentication) Emerging Markets: (Argentina, China, Turkey, India, etc.) have enacted Serialization regulations typically requiring Trace & Trace 13
14 Definitions: regulatory impact on operations Serialization Applying a unique identification code to the retail unit of sale GS1Standards Authentication Confirming the authenticity of the unique identification code, typically at the point of dispense Track and Trace Determining the location of product as it moves through the supply chain epedigree Documenting the chain of ownership of the product as it moves through the supply chain Aggregation and Inference (required for T&T) Every item, case and pallet is assigned a serial number Items are aggregated to cases (parent / child relationship) Cases are aggregated to pallets Unit level serial numbers can be inferred by reading the case or pallet serial number 14 14
15 Typically 1 integrated government report per mandate Integration with Trading Partners for traceability Some markets / other manufacturer s provision SNs DATA MANAGEMENT Internal Pharma Serialization Control Tower (SCT) External Pharma US EFPIA (Europe) Local Markets Brazil, China (Import), India Export, Korea, SA Phase II Role of Manufacturing, Logistics, CMOs Provision, apply and aggregate SNs Commission and notify SNs Manage inventory and SN data in parallel SUPPLY CHAIN Contract Mfg Packaging Line PharmaSite Pharma / CMO Plant Warehouse InterCompany & Market Logistics Sites/ LSP Wholesale Distributor Hospital / Pharmacy / Patient Key Serial Number Management Event Capture Reporting Data Transport /Product Flows Serialized Product Data 15
16 Serialization Program Structure Program Governance Supply Chain Security Executive Sponsor Program Governance Committee Corporate spokesperson Communicate business impact Elevate issues to Executive Team Endorse Program Deployment /Compliance Plan Endorse cost avoidance strategies (sourcing changes) Endorse investment deferrals and associated risks Participate in quarterly updates and elevate issues Program Operations Supply Network Enablement PMO Steering Team PMO Program Leads Capital Controls & Optimization Information Technology Enablement Oversight and guidance of PMO workstream activities Establish core solution strategies and scope Establish and monitor Program Deployment/Compliance Plan Stakeholder communication and awareness Day to day management of PMO Coordination of workstream activities Development of program metrics External Supply Enablement Industry Alignment / Customer Engagement Program Financial Management Supply Planning Enablement Logistics Enablement End User Chg Mgt & Training Market Enablement & Business Unit Engagement Program Operations Quality Operations 16
17 Serving patients is a privilege that comes with responsibilities Protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain 17 17
18 Thank you 18
Serialization and epedigree: New Opportunities for Life Sciences Manufacturers
Serialization and epedigree: New Opportunities for Life Sciences Manufacturers Table of Contents Serialization and epedigree: Current Direction... 3 Why Invest in Serialization?... 3 What Tasks do Life
More informationPresse-Information Press release Information de presse
Presse-Information Press release Information de presse Kontakt/Contact: Dr. Kathrin Rübberdt Tel. ++49 (0) 69 / 75 64-2 77 Fax ++49 (0) 69 / 75 64-2 72 e-mail: presse@dechema.de Trend Report February 2018
More informationTaking a Leap Toward Global Supply Chain Efficiency - Part II
Taking a Leap Toward Global Supply Chain Efficiency - Part II 2 Supply Chain Brochure - Part II INTRODUCTION Pharmaceutical manufacturers face a number of challenges in the production and delivery of medicinal
More informationSerialisation End User View
Serialisation End User View Agenda What is serialisation? Why do we serialise? Regulatory landscape and challenges Approaches to serialisation WHAT IS SERIALISATION? Packaging Levels Lowest saleable unit
More informationGS1 Ireland Healthcare User Group (HUG) Information Day
GS1 Ireland Healthcare User Group (HUG) Information Day FMD Implementation challenges for the manufacturers Joan Cahill, Pfizer 28 th March 2017 FMD Implementation Challenges Industry Perspective Joan
More informationBrand Protection: In the face of mounting counterfeiting, diversion & other infringements. Jim Mentone Director, Consumer Global Brand Protection
Brand Protection: In the face of mounting counterfeiting, diversion & other infringements Jim Mentone Director, Consumer Global Brand Protection Objective: Create active collaboration group MFGs & Retailers:
More informationPatients are Counting on Us: It s Time to Act
Patients are Counting on Us: It s Time to Act Brian Johnson Chairman Rx-360 Senior Director Supply Chain Security Pfizer, Inc. 24 th Global GS1 Healthcare Conference October 2, 2013 THE WALL STREET JOURNAL
More informationSerialization a global approach. Emanuele Tellaroli Key Account Manager ANTARES VISION
Serialization a global approach Emanuele Tellaroli Key Account Manager ANTARES VISION Beirut 02 June 2016 Serialization concept THE SMALLEST ITEM PUT ON SALE (selling unit) IS IDENTIFIED BY THE COMBINATION
More informationMass Serialization and Traceability Implementation in the Pharma Industry. Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland
Mass Serialization and Traceability Implementation in the Pharma Industry Mathieu Aman, Global Program Lead F. Hoffmann-La Roche Ltd, Switzerland What drives the industry towards more traceability Strategic
More informationGlobal Serialisation Developments and the Need for Convergence. Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015
Global Developments and the Need for Convergence Ulrike Kreysa, Vice-President, GS1 Global Office 3 rd June 2015 Developments across the world Regulatory bodies need to address Public Health issues one
More informationBeing Prepared for Track and Trace: DSCSA 101
Being Prepared for Track and Trace: DSCSA 101 Susanne Somerville, Founder The LinkLab Eric Garvin, Founder, The LinkLab Brian Daleiden, VP Industry Marketing and Co-Founder, TraceLink Objective of Today
More informationPatients are Counting on Us: A Little Less Conversation It s Time to Act
Patients are Counting on Us: A Little Less Conversation It s Time to Act Martin VanTrieste SVP Quality Amgen, Inc. PDA Missouri Valley Chapter Supply Chain Security in the Pharmaceutical Industry Thousand
More informationHealth Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center
Health Care Logistics: an Enabler of Change BioLogistics in a Changing Healthcare World Northwestern University Transportation Center Dave Bode VP, Health Care Solutions DSC Logistics April 20, 2016 Health
More informationValidation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October :30 12:00
Validation and Verification of Supply Chain: End-to-End Karen S Ginsbury For IVT: Workshop C 28 October 2014 08:30 12:00 Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel ONLY Pangea 7 May 2014 Israel
More informationA global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland)
Impressions Kaiseraugst A global view from the Pharmaceutical Industry Mathieu Aman F. Hoffmann-La Roche Ltd, Basel (Switzerland) SETRM2016 Rastreabilidade de Medicamento Sao Paulo, Jun 2016 Agenda Worldwide,
More informationGlobal Forum on Competition
Unclassified DAF/COMP/GF/WD(2014)51 DAF/COMP/GF/WD(2014)51 Unclassified Organisation de Coopération et de Développement Économiques Organisation for Economic Co-operation and Development 14-Feb-2014 English
More informationTrinity College Dublin QP Forum 2017 Tuesday 25 th April
Trinity College Dublin QP Forum 2017 Tuesday 25 th April HPRA QUESTIONS & ANSWERS 1. What is the approach being taken for audit of contamination control strategies as per chapters 3 & 5? What is the current
More informationHealth Care/Pharmaceutical. GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain
1 Health Care/Pharmaceutical GS1 Standards for Serialization and Visibility Within the U.S. Pharmaceutical Supply Chain 2 Health Care/Pharmaceutical: GS1 Standards for Serialization and Visibility Within
More informationPharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES
Pharma and Logistic Service Providers (LSP) Synergies and opportunities GDP, NEW EUROPEAN DIRECTIVES DB Schenker Healthcare Conference Europe April 17-18 th 2012 J. BERLO Industrial Pharmacist/Clin. Biol.
More information<1079> Good Storage and Distribution Practices
Good Storage and Distribution Practices Desmond Hunt, Ph.D. Principal Scientific Liaison September 7, 2017 Mexico City, Mexico Good Distribution Practice Activities Suppliers Procuring, holding,
More informationEssential Update on Contract Manufacturing and Quality Standards CPhI, Paris.
Essential Update on Contract Manufacturing and Quality Standards CPhI, Paris. Guy Villax 7 th of October 2014 Agenda Short Introduction to Hovione Driving Forces Shaping the Market CMOs Innovators and
More informationCorporate Presentation & Offer for SAP ATTP December 2015
Corporate Presentation & Offer for SAP ATTP December 2015 Page : 1 Page : 2 Content Our Vision Our Company Business Challenges SAP Advanced Track and Trace for Pharmaceuticals (ATTP) Our Offer Our Vision
More informationTop 15 Questions and Answers. EU FMD Safety Features and Verification
Top 15 Questions and Answers EU FMD Safety Features and Verification Now set for early 2019, the Delegated Act on safety features for the European Union (EU) Falsified Medicines Directive (FMD) has pharmaceutical
More informationGS1 Ireland Healthcare User Group (HUG) Information Day
GS1 Ireland Healthcare User Group (HUG) Information Day Overview on EU FMD regulation and unique identification requirements Geraldine Lissalde-Bonnet, GS1 Global Office 28 th March 2017 Overview on EU
More informationPfizer s Pedigree & RFID Pilots An Overview
An Overview Granada, February 2008 Tim Marsh Senior Manager Pfizer V-Tag C-Tag Pedigree Pilots Ongoing Work and Collaboration V-Tag Viagra RFID Pilot Mass Serialization at Item, Case and Pallet Level via
More informationWHITE PAPER. Solutions to Global Pharmaceutical Supply Chain Challenges
WHITE PAPER Solutions to Global Pharmaceutical Supply Chain Challenges Solutions to Global Pharmaceutical Supply Chain Challenges Find out how a contract packaging company can deliver the expertise and
More informationVerification of Pharmaceutical Products at the Point of Dispense. An EFPIA update
Verification of Pharmaceutical Products at the Point of Dispense Speaker : Grant Courtney Event: GS1 Global Conference Location: Washington An EFPIA update 1 Who is EFPIA? The European Federation of Pharmaceutical
More informationSE09. Track & Trace Solutions Jeff Bredemus Werner Electric
SE09 Track & Trace Solutions Jeff Bredemus Werner Electric Related Topics SE02 Balluff RFID SE03 Benefits of Image Based Barcode Reading SE08 Vision Solutions for the Food Ind. Solution Area 5 (Motion
More informationThe Blueprint approach
the way to comply with FMD and its Delegated Regulation: The Blueprint approach Johan Verhaeghe (FMD Project Manager) Frankfurt, 16 February 2016 EGA Vision 2020 To provide sustainable access to high quality
More informationUSP General Chapter <1079> Pharmacopeia Forum. for Drug Products
USP General Chapter Pharmacopeia Forum Good Storage and Transportation Practices for Drug Products IATA Vancouver/March 8-12, 2010 Mary Foster, PharmD USP Expert Committee Member, 2005-2010 2010
More informationCalifornia Prescription Drug Pedigree Requirements. Joshua A. Room Deputy Attorney General California Dept. of Justice Liaison Board of Pharmacy
California Prescription Drug Pedigree Requirements Joshua A. Room Deputy Attorney General California Dept. of Justice Liaison Board of Pharmacy A Few Words of Caution These are solely my own observations
More informationPharmaceutical RFID: From Mandates to Endorsements and Laws
Pharmaceutical RFID: From Mandates to Endorsements and Laws By Sara Shah, Industry Analyst, RFID and M2M Research, ABI Research The healthcare industry s motivation for adopting RFID can be attributed
More informationThe Danish Generic Medicines Industry Association (IGL)
The Danish Generic Medicines Industry Association (IGL) comments on the concept paper on the delegated act for a unique identifier for medicinal products for human use, and its verification. The Danish
More informationWHITE PAPER THE ANTI-COUNTERFEITING OF MEDICINES. EFPIA - November
WHITE PAPER ON THE ANTI-COUNTERFEITING OF MEDICINES EFPIA - November 2005 1 A. Introduction The EFPIA White Paper is intended to express the views of the European drug manufacturers, associated within
More informationDrug Supply Chain Security Act Implementation Track and Trace Issues in 2017
Drug Supply Chain Security Act Implementation Track and Trace Issues in 2017 ILISA BG BERNSTEIN, PharmD, JD Deputy Director, Office of Compliance FDA/CDER Presented at: FDLI DQSA Conference November 15,
More informationCharter on Access to Health in Developing Countries
Charter on Access to Health in Developing Countries Fake Medicines July 2014 Our Promise Merck is a leading company for innovative and top-quality high-tech products. As the oldest pharmaceutical and chemical
More informationSaudi Drug Code (SDC), and Drug Barcoding Specifications
Drug Sector Licensing Executive Directorate Guidance for Industry Saudi Drug Code (SDC), and Drug Barcoding Specifications This document outlines the SDC and the new drug barcode requirements for pharmaceuticals.
More informationSupplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan
Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification
More informationWhat Is Next After the Results of Implementing GS1 Pilot in the Public Health Supply Chains!
What Is Next After the Results of Implementing GS1 Pilot in the Public Health Supply Chains! ongoing progress in Pakistan Dr. Muhammad Tariq, Country Director, Pakistan Field Office USAID Global Health
More informationCTS East Coast. Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization. Connect with us to connect with Asia
Increasing Agility and Innovation in the Clinical Supply Chain for Cost Optimization Connect with us to connect with Asia CTS East Coast Oct 19 th, 2011 Philadelphia Introduction Zuellig Pharma Asia Pacific
More informationGuide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland
Guide to Wholesaling and Brokering of Medicinal Products for Human Use in Ireland IA-G0008-5 17 JUNE 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance
More informationChallenges to Building Quality End to End
Challenges to Building Quality End to End FDA/PQRI Conference- OCTOBER 2015 Michael Thien, Sc. D. SVP, Global Science, Technology & Commercialization Merck Manufacturing Division Two key dimensions of
More informationOverview of the Drug Supply Chain Security Act. GPhA Fall Technical Conference Bethesda, MD October 28, 2014
Overview of the Drug Supply Chain Security Act GPhA Fall Technical Conference Bethesda, MD October 28, 2014 Disclaimer This presentation contains a summary of the opinion and perspective from GPhA member
More informationSupplier Assurance Program. CBE Pty Ltd
Supplier Assurance Program CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without its express written permission.
More informationAnti-Slavery & Human Trafficking Report
PHOENIX Group UK Anti-Slavery & Human Trafficking Report Who we are The PHOENIX Pan European Group is one of the leading pharmaceutical distribution companies in Europe employing approximately 34,000 people.
More informationProject responsibilities
Project responsibilities Tallinn November 24th, 2017 Our Mission Falsified / counterfeit medicines are a serious risk for the citizens all around the world New legislation published on the 9th February
More informationHolding Your Suppliers Accountable
Holding Your Suppliers Accountable What Defines an Ingredient Supplier of Choice? David R. Schoneker Director of Global Regulatory Affairs dschoneker@colorcon.com 0 Supply Chain Accountability Why and
More informationThis article specifically covers incorporation of physical and chemical indicators (PCIDs) into or onto the drug product.
Introduction The pharmaceutical industry is criminalized with circulation of counterfeit drugs risking healthcare and the life of users. This has become quite menacing in recent times with the lure of
More informationTextvergleich. Verglichene Dokumente MEDIA3917.pdf. ICH_Q10_Step4.pdf
Textvergleich Verglichene Dokumente MEDIA3917.pdf ICH_Q10_Step4.pdf Übersicht 2270 Wort/Wörter hinzugefügt 1338 Wort/Wörter gelöscht 3558 Wort/Wörter übereinstimmend 157 Block/Blöcke übereinstimmend Blättern
More informationTitle II Licensure of Wholesale Distributors and 3PL s:
Title II Licensure of Wholesale Distributors and 3PL s: Where does FDA stand, where do states stand, what about VAWD, and what can you do about it? Elizabeth A. Gallenagh, Senior Vice President, Government
More informationFood Defense Supplier Guidelines
Food Defense Supplier Guidelines Revised: May 2015 Table of Contents Introduction 3 1. Program administration 3 a. Plan management 3 b. Roles and responsibilities 3 c. Reporting procedures 3 d. Self-assessments
More informationSERIALIZATION, TRENDS AND UPDATES. Lars Olsen Lundbeck, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark Thursday 21 September 2017
SERIALIZATION, TRENDS AND UPDATES Lars Olsen Lundbeck, Ottiliavej 9, 2500 Valby, Copenhagen, Denmark Thursday 21 September 2017 Biography Mr. Lars Olsen Global Technology Partner, NNE Dept. Global Best
More informationMaximiliano Derecho. National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina
Maximiliano Derecho National Administration of Drugs, Food and Medical Devices (ANMAT), Argentina Healthcare Conference 25/10/2016 EVOLUTION OF DRUGS TRACEABILITY IN ARGENTINA Dr. Maximiliano Derecho Legal
More informationTo effectively manage risks to supply chain performance, a public health supply chain manager should understand the following: THE LOGISTICS CYCLE
12 12 CHAPTER 12 SUPPLY CHAIN RISK MANAGEMENT FIGURE 11-1. THE LOGISTICS CYCLE Serving Customers WHAT A SUPPLY CHAIN MANAGER NEEDS TO KNOW: As detailed in this handbook, making health commodities available
More informationState Control of Medicines and Medical Devices in Russian Federation
Federal Service for Surveillance in Healthcare State Control of Medicines and Medical Devices in Russian Federation Ph.D., Elena Astapenko The Head of the Department of organization of state control and
More informationRetail Food Establishment. Self-Assessment Checklist. for. Food Defense
Retail Food Establishment Self-Assessment Checklist for Food Defense Ohio Department of Agriculture Division of Food Safety September 2005 Industry Self-Assessment Checklist for Food Defense On January
More informationSECURING THE SUPPLY CHAIN WITH SERIAL NUMBERS
SECURING THE SUPPLY CHAIN WITH SERIAL NUMBERS How secure mass serialization can help fight counterfeiting, diversion and theft. Verify Brand 3033 Campus Drive, Minneapolis MN 55441 info@verifybrand.com
More informationGuide to North America Healthcare Compliance 2016/2017
Guide to North America Healthcare Compliance 2016/2017 Dr. Reddy s Laboratories, Inc. NOTICE: this information is provided pursuant to the requirements of California Health & Safety Code 119400, 119402,
More informationFood Fraud. What you don t know could hurt you, your customer and your brand. Horse Meat? Copper Sulphate? Fertilizer?
Food Fraud What you don t know could hurt you, your customer and your brand Horse Meat? Copper Sulphate? Fertilizer? Olives coloured with copper sulphate. Counterfeit sugar contaminated with fertilizer.
More informationCollaboration: GS1 and Joint Initiative Council (JIC) in Healthcare
Collaboration: GS1 and Joint Initiative Council (JIC) in Healthcare International Organisation for Standardization European Committee for Standardization Health Level 7 international International Health
More informationBRIDGE Project Pharma Traceability GS1 Healthcare conference, 31 October 2007
Building Radio frequency IDentification solutions for the Global Environment BRIDGE Project Pharma Traceability GS1 Healthcare conference, 31 October 2007 Bridge Objectives To research and develop a set
More informationSecurity Engineering Services. Scalaris GRC Day 2011
Scalaris GRC Day 2011 Wednesday Feb. 2 nd 2011 11/01/2011 1 Presentation of Vesdo 11/01/2011 2 About Vesdo As internationally operating consulting engineers we exclusively focus on layout and realization
More informationQualified Persons in the Pharmaceutical Industry Study Guide
Qualified Persons in the Pharmaceutical Industry Study Guide Guide to the knowledge and practical experience required by Qualified Persons relating to pharmaceutical manufacturing in the UK February 2013
More informationFDA, Counterfeit, and RFID Technology
FDA, Counterfeit, and RFID Technology Edmund W. Schuster APICS members should note the implications of an article that appeared in the Wall Street Journal on February 19, 2004. Among other things, the
More informationRussian Pharmaceutical Market Trends in 2017 Track & trace system: additional costs or opportunities? Deloitte CIS Research Centre Moscow, 2017
Russian Pharmaceutical Market Trends in 27 Track & trace system: additional costs or opportunities? Deloitte CIS Research Centre Moscow, 27 Russian Pharmaceutical Market Trends in 27 Contents Russian in
More informationHolistic Serialization Solution
Holistic Serialization Solution Enhanced Serialization Solution from Rockwell Automation Provides a Scalable Platform for End to End Process Integration Features and Benefits Rockwell Automation offers
More informationGUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS
DRAFT VERSION GUIDELINES ON GOOD DISTRIBUTION PRACTICES FOR PHARMACEUTICAL PRODUCTS Published on the website of www.cdsco.nic.in on 10/01/2013 Notification The following draft guideline is hereby published
More informationProactive Approaches. To Minimize. Supply Chain Security. Breaches in the Rail, Air, Ocean and Land Environment
Proactive Approaches To Minimize Supply Chain Security Breaches in the Rail, Air, Ocean and Land Environment Top Eight Rail Principles Track and monitor pulls on a 24 hour basis to determine location and
More informationRomania. Raluca Vasilescu Cabinet M Oproiu. Pharmaceutical Trademarks 2015/2016. A Global Guide
Romania Raluca Vasilescu Cabinet M Oproiu Pharmaceutical Trademarks 2015/2016 A Global Guide Romania Cabinet M Oproiu Author Raluca Vasilescu Selection, clearance and registration In Romania, pharmaceutical
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationUNICEF Quality Assurance in the procurement of medicines
UNICEF Quality Assurance in the procurement of medicines Peter S. Jakobsen 30 October 2006 Quality Assurance Centre SUPPLY DIVISION Today s presentation addresses 3 questions: How is UNICEF involved in
More informationMAIMONIDES MEDICAL CENTER
MAIMONIDES MEDICAL CENTER CODE: AD-088 (Revised) ORIGINALLY ISSUED: October 2, 1990 SUBJECT: Product Safety Recall and Alert I POLICY In the event of a product safety recall or alert of a medical device
More informationRe-engineering the external drug supply chain
Re-engineering the external drug supply chain EAHP Prof. dr. Ad R. van Goor Barcelona 26 + 27 March 2014 Agenda Future Value Chain 2020 Pharma Supply Chain Supply Chain Aspects Pharma Logistics Supply
More informationBarcodes on Unit of Use
Barcodes on Unit of Use 1 What hospitals need Hospitals need medications Ready-to-Administer In Unit-of-Use With Barcode 2 What hospitals need Ready-to-Administer If not, must go through additional pharmacy
More informationCorporate Responsibility Guideline
Corporate Responsibility Guideline Novartis Global Guideline Group guidance on governance, roles and responsibilities, and management of corporate responsibility across Novartis Approved: October 2014
More informationChapter 12 Marketing Channels and Supply Chain Management
Chapter 12 Marketing s and Supply Chain Management The Place Component of the Marketing Mix: s of Distribution Logistics Materials Management Physical Distribution Marketing s A set of interdependent organizations
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Complex Business Models - Outsourced Activities Presented by: Jacqueline Masayi, GDP Inspector Background Increased complexities of the
More informationRegulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017
Regulatory Update: The US Drug Supply Chain Security Act (DSCSA) December 2017 Regulatory Agency Regulation Name or System Name Compliance Dates U.S. Department of Health and Human Services (HHS), Food
More informationQuality Agreements and Managing Contract Supplier Quality
Quality Agreements and Managing Contract Supplier Quality American Society for Quality Lloyd Bailey November 3, 2005 Service Mark of The Dow Chemical Company TM Trademark of The Dow Chemical Company Abstract
More informationPrescription Product Supplier Requirements
Prescription Product Supplier Requirements Prescription Product Suppliers: Prescription product suppliers are those suppliers that manufacture, package, or distribute a prescription pharmaceutical (drug)
More informationCDER Office of Compliance Priorities and focus
CDER Office of Compliance Priorities and focus ILISA B.G. BERNSTEIN, Pharm.D., J.D. Deputy Director, Office of Compliance Center for Drug Evaluation and Research U.S. Food and Drug Administration Pharmaceutical
More informationUNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products
UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September
More informationDr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority
CHALLENGES AND OPPORTUNITIES IN COLD CHAIN: HEALTH CARE RELATED DRIVERS Dr. Abdulrahman Mohammad Al Jassmi Chief Executive Officer Dubai Hospital Dubai Health Authority AGENDA Integrating stakeholders
More informationThe Global Healthcare User Group GS1 HUG - Newsletter No. 1
The Global Healthcare User Group GS1 HUG - Newsletter No. 1 Welcome to the first edition of the GS1 HUG Newsletter! We have initiated this newsletter to inform you about our activities and progress in
More informationQuality Agreements with CMO s. Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals
Quality Agreements with CMO s Presented at ASQ Orange Empire Meeting May 13, 2014 By Luke Foo Sr. Director QA/QC Spectrum Pharmaceuticals FDA Guidance Contract Manufacturing Arrangements for Drugs: Quality
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY. EudraLex. Volume 4
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Ref. Ares(2015)4234460-12/10/2015 Medicinal products quality, safety and efficacy Brussels, 12 October 2015 EudraLex Volume 4 EU Guidelines
More informationOVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS IN EMERGING MARKET
Badjatya et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), 227-232 227 Available online at http://jddtonline.info REVIEW ARTICLE OVERVIEW OF DRUG REGISTRATION REQUIREMENTS FOR PHARMACEUTICALS
More informationThomas J. Cosgrove, Director, Office of Manufacturing Quality, CDER, FDA
Thomas J. Cosgrove, Director, Office of Manufacturing Quality, CDER, FDA 1 Cynthia Schnedar Executive Vice President, Regulatory Compliance Greenleaf Health 2 Minimizing risk at all stages of supply chain,
More informationGuide to Scientific and Regulatory Advice for GXP activities
Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More informationGS1 Turkey Yeliz Geriş. İTS -Turkish Pharmaceutical Track and Trace System
GS1 Turkey Yeliz Geriş İTS -Turkish Pharmaceutical Track and Trace System What is İTS? İTS-Pharmaceutical Track & Trace System Project Phases Implementation Timeline Objectives Scope Labeling Workflow
More informationGlobal Perspectives on E-Government
Global Perspectives on E-Government Hongren Zhou, Ph.D. Interregional Adviser The United Nations Department of Economic and Social Affairs December 11, 2001, Jamaica Nature of E-Government: Existing traditional
More informationQUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION
PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction
More information3-pin plug & footwear nightmares Dr Peter Stevens Chief Executive
New Zealand 3-pin plug & footwear nightmares Dr Peter Stevens Chief Executive Peter.Stevens@gs1nz.org New Zealand 2009 GS1 New Zealand Pharma - Europe coding & serialisation requirements Cyprus - 2010
More informationHow blockchain. the modern. supply chain. How Blockchain will. supply chain
How blockchain will transform How Blockchain will transform the modern the modern supply chain supply chain Introduction Complex supply chains require trust Contemporary supply chains have opened up a
More informationCurrent Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing.
Current Global GMP Status and Trends With Focus on EU & PIC/S JPMA Annual Meeting, Tokyo & Osaka, September 2012 Dr.-Ing. Stephan Rönninger Pharma Medicines Technical Operations Global Quality & Compliance,
More informationLabeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies
Labeling Best Practice in a Challenging Manufacturing Landscape A survival guide for pharmaceutical companies White Paper www.nicelabel.com/pharma 1 1 Executive summary The number of challenges for the
More informationGDP for APIs New Regulations. we prove it. The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle
1 - Temperature Control Challenges - Full Lifecycle Monitoring WHITE PAPER GDP for APIs New Regulations The Shift to Monitoring BioPharma Product Quality Throughout Their Lifecycle we prove it. 2 GDP for
More informationGIRP comments on. The vital link in healthcare 1. European Association of Pharmaceutical Full-line Wholesalers
GIRP comments on Guidelines on the principles of Good Distribution Practices for active substances for medicinal products for human use submitted for public consultation Introduction: GIRP, the European
More informationMHRA GDP Symposium. Novotel London West, London 8 & 10 December #GMDPevents
MHRA GDP Symposium Novotel London West, London 8 & 10 December 2015 Deficiencies in GDP Phil Neale, GDP Operations Manager Tony Orme, GDP Senior Inspector. Finding deficiencies in GDP is not only for those
More information